Why the study?
What is the optimal duration and type of long-term anticoagulant therapy for patients after venous thromboembolism?
What is the optimal duration and type of long-term anticoagulant therapy for patients after venous thromboembolism?
The duration of anticoagulant therapy for VTE should be individualized based on the risk of recurrence versus bleeding, ranging from 3 months for provoked VTE to indefinite for unprovoked or cancer-associated VTE.
No takes yet. Share an insight, caveat, or question.
Balances recurrence vs bleeding risks post-VTE; supports risk-stratified guidelines while leaving optimal long-term duration open.
Clive Kearon (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: